HomeRubricheSaporiCirculation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field...

Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

- Advertisement -

Findings presented at the International VT Symposium and published simultaneously in Circulation.—immediapress/pr-newswirewebinfo@adnkronos.com (Web Info)

- Advertisement -
ARTICOLI CORRELATI

LASCIA UN COMMENTO

Per favore inserisci il tuo commento!
Per favore inserisci il tuo nome qui

- Advertisment -

Most Popular

- Advertisement -